Stockholm score of lesion detection on computed tomography following mild traumatic brain injury (SELECT-TBI): study protocol for a multicentre, retrospective, observational cohort study

Autor: Li Yang, Therese Djärv, Jiri Bartek, Emeli Pontén, Magnus Boman, Lovisa Strömmer, Alexander Fletcher‑Sandersjöö, Charles Tatter, Philipp Lassarén, Sune Forsberg, Ingrid Grönlund, Viktor Tidehag, Rebecka Rubenson-Wahlin, Karin Westberg, Kristian Ängeby, Olof Lundblad, Eric Peter Thelin

Publikováno v: BMJ Open, Vol 12, Iss 9 (2022)

Introduction Mild traumatic brain injury (mTBI) is one of the most common reasons for emergency department (ED) visits. A portion of patients with mTBI will develop an intracranial lesion that might require medical or surgical intervention. In these

Externí odkaz: https://doaj.org/article/6dba98d7f8d145de8b487f9048601a86

Risk factors for traumatic intracranial hemorrhage in mild traumatic brain injury patients at the emergency department: a systematic review and meta-analysis

Autor: Li Jin Yang, Philipp Lassarén, Filippo Londi, Leonardo Palazzo, Alexander Fletcher-Sandersjöö, Kristian Ängeby, Eric Peter Thelin, Rebecka Rubenson Wahlin

Publikováno v: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 32, Iss 1, Pp 1-15 (2024)

Abstract Background Mild traumatic brain injury (mTBI), i.e. a TBI with an admission Glasgow Coma Scale (GCS) of 13–15, is a common cause of emergency department visits. Only a small fraction of these patients will develop a traumatic intracranial

Externí odkaz: https://doaj.org/article/8df177c37ffc4d9dae3e5522f2d1cc03

A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19

Autor: Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, Jonathan Grip, Mårten Söderberg, Jacob Hollenberg, Rebecka Rubenson Wahlin, Thomas Kander, Liivi Rimling, Johan Mårtensson, Eva Joelsson-Alm, Martin Dahlberg, Maria Cronhjort

Publikováno v: Thrombosis Journal, Vol 21, Iss 1, Pp 1-11 (2023)

Abstract Background Patients with critical COVID-19 have a high risk of thromboembolism, but intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-weight heparins can be monitored by measuring anti-Factor Xa. We

Externí odkaz: https://doaj.org/article/198c0dae5b6846be8b392a23e45025fa

Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial

Autor: Sandra Jonmarker, Felix Alarcón, Jacob Litorell, Anders Granholm, Eva Joelsson Alm, Michelle Chew, Lene Russell, Sarah Weihe, Emilie Kabel Madsen, Nick Meier, Jens Wolfgang Leistner, Johan Mårtensson, Jacob Hollenberg, Anders Perner, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Martin Dahlberg, Maria Cronhjort, Rebecka Rubenson Wahlin

Publikováno v: Annals of Intensive Care, Vol 13, Iss 1, Pp 1-10 (2023)

Abstract Background Thromboembolism is more common in patients with critical COVID-19 than in other critically ill patients, and inflammation has been proposed as a possible mechanism. The aim of this study was to investigate if 12 mg vs. 6 mg dexame

Externí odkaz: https://doaj.org/article/3731ee9446b7446d83c1c7da2859941b

Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial

Autor: Anders Granholm, Marie Warrer Munch, Nina Andersen‐Ranberg, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Balasubramanian Venkatesh, Vivekanand Jha, Rebecka Rubenson Wahlin, Stephan M. Jakob, Luca Cioccari, Morten Hylander Møller, Anders Perner

Publikováno v: Granholm, A, Munch, M W, Andersen-Ranberg, N, Myatra, S N, Vijayaraghavan, B K T, Venkatesh, B, Jha, V, Wahlin, R R, Jakob, S M, Cioccari, L, Møller, M H & Perner, A 2023, ' Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial ', Acta Anaesthesiologica Scandinavica, vol. 67, no. 2, pp. 195-205 . https://doi.org/10.1111/aas.14167

Background: Corticosteroids improve outcomes in patients with severe COVID-19. In the COVID STEROID 2 randomised clinical trial, we found high probabilities of benefit with dexamethasone 12 versus 6 mg daily. While no statistically significant hetero

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1666f090651e5386bc42198dcadae3e0
https://curis.ku.dk/ws/files/338308813/Acta_Anaesthesiol_Scand_2022_Granholm_Heterogeneous_treatment_effects_of_dexamethasone_12_mg_versus_6_mg_in_patients.pdf